CDTX stock news
This page provides real-time market news, earnings updates, and company announcements related to Cidara Therapeutics, Inc. (CDTX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-07 13:19 EST
JPMorgan’s Competitive Advantage: Healthcare and Financial Sectors Flourish as Markets Evolve
Bitget-RWA2025-11-19 18:04:20
Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade
101 finance2026-01-15 12:24:24
Merck forecasts 2026 sales below estimates on patent losses
101 finance2026-02-03 11:39:32
Merck's quarterly results exceed expectations, but conservative 2026 guidance issued due to generic drug competition
新浪财经2026-02-03 13:26:14
MRK Up More Than 7% on Improved Long-Term Prospects: Still a Sell?
Finviz2026-02-13 16:51:41
Merck Indicates Better Growth Visibility in Post-Keytruda LOE Period
Finviz2026-02-16 17:48:11
Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026?
Finviz2026-02-20 18:06:38
RBC Capital Sees Merck (MRK) Returning to Growth Sooner Than Market Expects
Finviz2026-02-26 02:51:37
Baron Health Care Fund Q4 2025: Analyzing Portfolio Strategy, High-Conviction Investments, and Structural Headwinds
101 finance2026-03-03 15:54:57
Merck (MRK) Shares Rise 1.7% Following Recent Earnings: Will the Momentum Last?
101 finance2026-03-05 17:36:45
J&J versus Merck: Crucial Considerations Investors Should Evaluate at This Moment
101 finance2026-03-18 15:16:08
Merck’s Strategic Move with Terns Pharma: A Bold Oncology Investment in a Competitive Market
101 finance2026-03-25 01:57:41
Merck’s Terns Pharma Buy: A High-Stakes Play on a Rare-Cancer Catalyst Before Keytruda’s Patent Cliff
101 finance2026-03-25 03:04:15
Merck to Expand Cancer Portfolio Through $6.7B Acquisition of Terns, Shares Rise
101 finance2026-03-26 16:13:06
Merck Shares Surge 50% Over Half a Year: Should You Buy, Hold, or Cash Out?
101 finance2026-03-27 14:07:13
Can MRK's Continued Acquisition Strategy Support Sustainable Expansion as Keytruda Faces Patent Expiry?
101 finance2026-03-27 14:09:57
Pharma's M&A Reset: Vertical Integration and Platform Control Drive Conviction Buys in 2025
101 finance2026-03-31 22:03:48
Merck's Strategy for Patent Extension Presents Unique Alpha Opportunity During $70B Expansion Shift
101 finance2026-04-06 04:51:47
MRK Up More Than 7% on Improved Long-Term Prospects: Still a Sell?
Finviz2026-02-13 16:51:41
Merck Indicates Better Growth Visibility in Post-Keytruda LOE Period
Finviz2026-02-16 17:48:11
Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026?
Finviz2026-02-20 18:06:38
RBC Capital Sees Merck (MRK) Returning to Growth Sooner Than Market Expects
Finviz2026-02-26 02:51:37
Baron Health Care Fund Q4 2025: Analyzing Portfolio Strategy, High-Conviction Investments, and Structural Headwinds
101 finance2026-03-03 15:54:57
Merck (MRK) Shares Rise 1.7% Following Recent Earnings: Will the Momentum Last?
101 finance2026-03-05 17:36:45
J&J versus Merck: Crucial Considerations Investors Should Evaluate at This Moment
101 finance2026-03-18 15:16:08
Merck’s Strategic Move with Terns Pharma: A Bold Oncology Investment in a Competitive Market
101 finance2026-03-25 01:57:41
Merck’s Terns Pharma Buy: A High-Stakes Play on a Rare-Cancer Catalyst Before Keytruda’s Patent Cliff
101 finance2026-03-25 03:04:15
Merck to Expand Cancer Portfolio Through $6.7B Acquisition of Terns, Shares Rise
101 finance2026-03-26 16:13:06
Merck Shares Surge 50% Over Half a Year: Should You Buy, Hold, or Cash Out?
101 finance2026-03-27 14:07:13
Can MRK's Continued Acquisition Strategy Support Sustainable Expansion as Keytruda Faces Patent Expiry?
101 finance2026-03-27 14:09:57
Pharma's M&A Reset: Vertical Integration and Platform Control Drive Conviction Buys in 2025
101 finance2026-03-31 22:03:48
Merck's Strategy for Patent Extension Presents Unique Alpha Opportunity During $70B Expansion Shift
101 finance2026-04-06 04:51:47
CDTX stock chart
CDTX stock detailsCDTX stock price change
On the last trading day, CDTX stock closed at 221.38 USD, with a price change of 0.03% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more